Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China Pharmaceutical Companies Seek Opportunities Overseas

This article was originally published in PharmAsia News

Executive Summary

Beijing Second Pharmaceutical, a subsidiary of Beijing Pharmaceutical Group, will collaborate with U.S.-based Frontage Laboratories to jointly develop 12 products for abbreviated new drug applications in the next five years. The new drugs will be marketed in China, the U.S. and European countries. In addition, Second Pharmaceutical has signed a strategic agreement with Poland's Adamed to cooperate on import and export registration, original equipment manufacturing and marketing. It is also working with an American pharmaceutical distributor to market these drugs internationally. Currently, more than 10 Chinese firms have received U.S. and EU cGMP authentication and applied for U.S. FDA approval of their drugs. These include Guangdong Oriental Sunshine Pharmaceuticals and Shanghai Sine Pharma Laboratory. Analysts observe that global demand of quality inexpensive generic drugs will give Chinese companies an edge. (Click here for more - Chinese Language)
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC071197

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel